Sanofi Stock Today

SNYNF Stock  USD 99.70  0.26  0.26%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 9

 
100  
 
Zero
Low
Sanofi is trading at 99.70 as of the 28th of March 2024. This is a -0.26 percent decrease since the beginning of the trading day. The stock's lowest day price was 99.7. Sanofi has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Sanofi are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of June 2022 and ending today, the 28th of March 2024. Click here to learn more.
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was founded in 1973 and is headquartered in Paris, France. Sanofi-Aventis operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. The company has 1.25 B outstanding shares. More on Sanofi

Moving together with Sanofi Pink Sheet

  0.77RHHBF Roche Holding AGPairCorr
  0.84RHHBY Roche HoldingPairCorr
  0.84RHHVF Roche Holding AGPairCorr
  0.69AZNCF AstraZeneca PLCPairCorr

Moving against Sanofi Pink Sheet

  0.69LLY Eli Lilly And Financial Report 25th of April 2024 PairCorr
  0.49MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Sanofi Pink Sheet Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sanofi's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sanofi or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOOlivier Brandicourt
Business ConcentrationDrug Manufacturers—General, Healthcare (View all Sectors)
Sanofi [SNYNF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Mega-Cap' category with a current market capitalization of 120.25 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sanofi's market, we take the total number of its shares issued and multiply it by Sanofi's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sanofi classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.25 B outstanding shares. Sanofi has accumulated about 6.9 B in cash with 10.52 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.51.
Check Sanofi Probability Of Bankruptcy
Ownership Allocation
Sanofi maintains a total of 1.25 Billion outstanding shares. 30% of Sanofi outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Sanofi Ownership Details

Sanofi Stock Price Odds Analysis

In reference to a normal probability distribution, the odds of Sanofi jumping above the current price in 90 days from now is about 29.63%. The Sanofi probability density function shows the probability of Sanofi pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Sanofi has a beta of -0.2482. This usually implies as returns on benchmark increase, returns on holding Sanofi are expected to decrease at a much lower rate. During the bear market, however, Sanofi is likely to outperform the market. Additionally, sanofi has an alpha of 0.0941, implying that it can generate a 0.0941 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 99.7HorizonTargetOdds Above 99.7
70.10%90 days
 99.70 
29.63%
Based on a normal probability distribution, the odds of Sanofi to move above the current price in 90 days from now is about 29.63 (This Sanofi probability density function shows the probability of Sanofi Pink Sheet to fall within a particular range of prices over 90 days) .

Sanofi Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Sanofi market risk premium is the additional return an investor will receive from holding Sanofi long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Sanofi. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Sanofi's alpha and beta are two of the key measurements used to evaluate Sanofi's performance over the market, the standard measures of volatility play an important role as well.

Sanofi Stock Against Markets

Picking the right benchmark for Sanofi pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Sanofi pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Sanofi is critical whether you are bullish or bearish towards Sanofi at a given time. Please also check how Sanofi's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Sanofi without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Correlation Analysis Now

   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Module

Sanofi Corporate Directors

Sanofi corporate directors refer to members of a Sanofi board of directors. The board of directors generally takes responsibility for the Sanofi's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Sanofi's board members must vote for the resolution. The Sanofi board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Emmanuel BabeauIndependent DirectorProfile
Fabienne LecorvaisierDirectorProfile
Klaus PohleIndependent DirectorProfile
Bernard CharlesIndependent DirectorProfile

How to buy Sanofi Pink Sheet?

Before investing in Sanofi, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Sanofi. To buy Sanofi stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Sanofi. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Sanofi stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Sanofi stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Sanofi stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Sanofi, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Sanofi?

The danger of trading Sanofi is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Sanofi is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Sanofi. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Sanofi is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Sanofi Pink Sheet analysis

When running Sanofi's price analysis, check to measure Sanofi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi is operating at the current time. Most of Sanofi's value examination focuses on studying past and present price action to predict the probability of Sanofi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi's price. Additionally, you may evaluate how the addition of Sanofi to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Please note, there is a significant difference between Sanofi's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.